Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia
|
|||||
Results of a clinical trial show contact lenses that focus light on multiple areas of the retina reduce near-sightedness in children. . . . → Read More: Muti-Focus Contact Lenses Slow Children’s Myopia A company using image analysis and deep learning to discover therapies for diseases often considered difficult to treat is raising $123 million in new venture funds. . . . → Read More: A.I. Discovery Company Raises $123M in Venture Funds A clinical trial is underway assessing a drug approved for a rare inherited disease as a treatment for people hospitalized with pneumonia from Covid-19 infections. . . . → Read More: Trial Testing Rare Disease Drug for Covid-19 Pneumonia Discoveries in a university lab that enable detection of Covid-19 infections from a person’s breath are being licensed for development by a biotechnology company. . . . → Read More: Breath Analysis Sensor Licensed to Detect Covid-19 Seven new vaccine projects got underway last week, raising the total to 164, with six more vaccines reaching clinical trials now totaling 41. . . . → Read More: Covid-19 Vaccines, Therapies – 10 August 2020 Physical symptoms experienced by people with Covid-19 infections are well documented over the past few months, but the psychological toll is also beginning to get attention. . . . → Read More: Infographic – Mental Health Effects of Pandemic The genome of the Asian giant hornet, a species threatening bees and humans, was analyzed, with the data released by the Agricultural Research Service. . . . → Read More: Giant Hornet Genome Sequenced A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California. . . . → Read More: Grant Funds Placenta Stem Cell Trial Sites for Covid-19 GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases. . . . → Read More: Start-Up to Engineer T-Cells for Autoimmune Diseases A new venture fund plans investments in early-stage life science companies addressing critical needs in therapeutics, but also agriculture and industrial biotechnology. . . . → Read More: Venture Fund Plans $350M for Biotech Start-Ups |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |